Overview
Rasalect 0.5 mg Tablets contain Rasagiline, a monoamine oxidase-B (MAO-B) inhibitor indicated for the treatment of Parkinson’s disease. It enhances the levels of dopamine in the brain, thereby improving motor symptoms such as tremors, stiffness, and slowed movement. This dosage strength is often used to initiate treatment or as part of a titration plan, especially when used with other Parkinson’s medications like levodopa.





